Xinghong Leng

1 article listing Xinghong Leng in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart Nature Communications